David Lehman serves as the General Counsel at Pulmonx Corp, a company dedicated to advancing treatments for patients with chronic obstructive pulmonary disease (COPD) through its minimally invasive solutions. In his role, Lehman is responsible for overseeing all legal affairs of the company, ensuring compliance with regulatory requirements, and providing strategic guidance to the executive team. His expertise in corporate law and healthcare regulations has been instrumental in navigating the complex landscape of medical device innovation and commercialization. Before joining Pulmonx Corp, Lehman built a robust career in the legal field, with a focus on life sciences and healthcare. He previously worked at several prominent law firms where he advised clients on a wide range of issues, including intellectual property, mergers and acquisitions, and corporate governance. Lehman's deep understanding of the industry, combined with his strategic approach to legal challenges, has earned him a reputation as a trusted advisor in the healthcare sector. His contributions have been pivotal in supporting Pulmonx Corp's growth and its mission to improve the quality of life for patients with severe lung disease. Lehman's achievements extend beyond his professional role, as he is also actively involved in industry associations and legal committees that focus on advancing healthcare law and policy. His commitment to excellence and innovation in the legal field has not only benefited Pulmonx Corp but has also contributed to the broader healthcare community. Under his leadership, Pulmonx Corp continues to thrive, pushing the boundaries of what is possible in COPD treatment and setting new standards for patient care.